• Careers
  • Events
  • Library
  • Global Reach
logo-small.png
  • Why Veristat
    • About Us
    • Our Approach
    • Our Leadership
    • Success Stories
    • News
    • Locations
    • Careers
      • Open Positions
      • Core Values
      • Explore Benefits
      • Grow Your Career
      • Because We Care
      • Why Veristat
  • Therapeutic Areas
    • Oncology
    • Infectious Disease
    • Endocrine/Metabolic
    • CNS/Neurology
    • Cardiovascular Disease
    • Coronavirus
    • More Therapy Areas
  • Solutions
    • Cell and Gene Therapies
    • Virtual Trials
    • Rare Diseases
    • Rescue Trials
    • Vaccine Trials
    • Full Service
      • Clinical Trial Planning
      • Clinical Trial Conduct
      • Regulatory Submission
  • Services
    • Full Service
      • Clinical Trial Planning
      • Clinical Trial Conduct
      • Regulatory Submission
    • Strategic Consulting
      • Adaptive Designs
    • Regulatory Affairs
      • Regulatory Consulting
      • Marketing Applications
      • Agency Meetings
      • Regulatory Publishing
    • Clinical Operations
      • Project Management
      • Monitoring & Site Management
      • Patient Recruitment
      • Patient Retention & Site Engagement
    • Medical Affairs
      • Clinical Trial Safety
      • Data Review Committees
      • Medical Monitoring
    • Medical Writing
    • Biometrics
      • Data Management
      • Biostatistics
      • Statistical Programming
      • Standards Implementation
    • Pharmacovigilance
  • Knowledge Base
    • Library
    • Blog
    • Webinars
    • Success Stories
    • Newsletter
  • Contact Us
  • RFP

Robin Bliss, PhD

Veristat Thought Leader Biography

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

Contact Veristat Now


Request A Proposal

Contact Us


Bliss_Robin_websiteheadshot.jpg

Robin Bliss, PhD

Director, Biostatistics

Robin is a Director of Biostatistics at Veristat.  She oversees the operations of the biostatistics department and collaborates with all the integrated operational teams throughout the clinical trial  and regulatory submission process to help produce high quality statistical deliverables.

She has over 12 years of experience in clinical biostatistics, is very experienced with designing and implementing adaptive clinical trials.   Robin has worked with both the United States Food & Drug Administration (FDA) and Japan's Pharmaceutical and Medical Devices Agency (PMDA) to defend adaptive design trials for clients.   Her knowledge and  expertise span a broad range of therapeutic and product indications including oncology, rare diseases, vaccines and devices/diagnostics. Throughout her career, Robin has participated in over 30 publications and continues to provide peer review for a variety of organizations. She earned her PhD and MA from Boston University and her BA in Mathematics from Williams College in Williamstown, MA.


Explore Related Services

  • Biostatistics
  • Regulatory Submissions
  • Clinical Operations
  • Statistical Programming
Contact Us
Request A Proposal

Get Updates

  • Why Veristat
    • About Us
    • Our Approach
    • Our Leadership
    • Success Stories
    • News
    • Locations
    • Careers
  • Therapeutic Areas
    • Oncology
    • Infectious Disease
    • Endocrine/Metabolic
    • CNS/Neurology
    • Cardiovascular Disease
    • Coronavirus
    • More Therapy Areas
  • Solutions
    • Cell and Gene Therapies
    • Virtual Trials
    • Rare Diseases
    • Rescue Trials
    • Vaccine Trials
    • Full Service
  • Services
    • Full Service
    • Strategic Consulting
    • Regulatory Affairs
    • Clinical Operations
    • Medical Affairs
    • Medical Writing
    • Biometrics
    • Pharmacovigilance
  • Knowledge Base
    • Library
    • Blog
    • Webinars
    • Success Stories
    • Newsletter
  • Careers
    • Open Positions
    • Core Values
    • Explore Benefits
    • Grow Your Career
    • Because We Care
    • Why Veristat
  • Privacy Policy
  • ©2006 - 2021 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat, LLC. All other trademarks are the property of their respective owners.